Access to innovation in oncology from patients' perspectives: a qualitative systematic review

从患者角度探讨肿瘤学创新成果的获取:一项定性系统评价

阅读:1

Abstract

BACKGROUND: Access to innovation in oncology is commonly examined from technical, organisational, or economic perspectives, yet less is known about how patients experience access along cancer care pathways. This study synthesised qualitative evidence on adult patients' experiences of accessing innovation. METHODS: We conducted a qualitative systematic review between Sept 1 and Oct 24, 2025, using the Joanna Briggs Institute meta-aggregation approach. MEDLINE, PsycINFO, Cairn.info, and OpenEdition were searched. Eligible studies reported adult patients' experiences of access to innovation in oncology. Findings were appraised, grouped by similarity in meaning, and aggregated into synthesised findings. Confidence was assessed using the ConQual approach. This review is registered with PROSPERO, CRD420251046315. FINDINGS: 20 studies involving 306 patients were included. We identified 209 findings, grouped into 13 categories and four synthesised findings. Access to innovation was described as depending on accessible information, continuity of care, conditions supporting self-management, and the availability of spaces not centred on disease. INTERPRETATION: Access to innovation extends beyond availability or eligibility. It emerges as a dynamic process shaped by time, care relationships, personal resources, and organisational context. Aligning innovation with patients' lived experiences may support more equitable access. FUNDING: The Integrated Cancer Research Centre (SIRIC) InsiTu: Insights into Cancer: From Inflammation to Tumour.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。